Suppr超能文献

高、低传染病地区活化 B 细胞样弥漫性大 B 细胞淋巴瘤患者具有不同的炎症基因特征。

Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures.

机构信息

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Leuk Lymphoma. 2013 May;54(5):996-1003. doi: 10.3109/10428194.2012.738365. Epub 2012 Nov 8.

Abstract

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with an association with inflammation and viral infections. We hypothesize that environmental factors may be involved in the pathogenesis of DLBCL. In this study, we compared gene expression profiles of lymph node tissues from patients with DLBCL from two different geographical areas with diverse environmental exposures. Specimens from Egyptian and Swedish patients with DLBCL as well as controls were studied. Gene expression analysis using microarray and quantitative polymerase chain reaction demonstrated significantly higher expression of signal transducer and activator of transcription 3 (STAT3) in Swedish as compared to Egyptian patients and control materials from both countries. This was confirmed at protein level using confocal microscopy. The receptor tyrosine kinase ROR1, a "survival factor" for malignant cells, was overexpressed and significantly related to the STAT3 expression pattern. The difference in the expression of genes involved in inflammatory responses and in the tumorigenic process of DLBCL might relate to infectious agents and/or other environmental exposures.

摘要

弥漫性大 B 细胞淋巴瘤(DLBCL)是一种具有炎症和病毒感染相关性的异质性疾病。我们假设环境因素可能参与 DLBCL 的发病机制。在这项研究中,我们比较了来自两个具有不同环境暴露的地理位置的 DLBCL 患者的淋巴结组织的基因表达谱。研究了来自埃及和瑞典的 DLBCL 患者以及对照者的标本。使用微阵列和定量聚合酶链反应的基因表达分析表明,与埃及患者和来自两个国家的对照材料相比,瑞典患者的信号转导和转录激活因子 3(STAT3)表达明显更高。使用共聚焦显微镜证实了这一点。受体酪氨酸激酶 ROR1 是恶性细胞的“生存因子”,其过度表达并与 STAT3 表达模式显著相关。涉及炎症反应和 DLBCL 肿瘤发生过程的基因表达的差异可能与感染因子和/或其他环境暴露有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验